Source: Eur Respir Monogr 2014; 64: 65-76
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Anil Mehta, Olaf Sommerburg, Kevin W. Southern. Newborn screening for cystic fibrosis: opportunities and remaining challenges. Eur Respir Monogr 2014; 64: 65-76

Member's Comments

No comment yet.

Related content which might interest you: Newborn screening and carrier screening for cystic fibrosis: alternative or complementary? Source: Eur Respir J 2014; 43: 20-23 Year: 2004 Challenges of providing care to adults with cystic fibrosis Source: Eur Respir Monogr 2014; 64: 286-303 Year: 2014 Newborn screening for cystic fibrosis - lessons from national programmes in Europe Source: International Congress 2018 – PG10 Cystic fibrosis: Basic defects and clinical problems in children Year: 2018 A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases Year: 2021 Should the D1152H variant be included in cystic fibrosis newborn screening programmes? Source: Virtual Congress 2020 – Cystic fibrosis Year: 2020 The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Case study in cystic fibrosis: the US CF Foundation research and clinical development programmes Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines Year: 2014 1-PRO "Newborn screening for cystic fibrosis should be added to routine newborn screening programmes" Source: Annual Congress 2010 - Pro/Con debates: 1. To screen or not to screen for cystic fibrosis: is it still the question, 2. Specific immunotherapy for asthma Year: 2010 Newborn screening for cystic fibrosis: pros and cons Source: Breathe 2011; 8: 24-30 Year: 2011 Genomically-guided therapies: a new era for cystic fibrosis Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases Year: 2020 Adults with cystic fibrosis and pulmonologists: new training needed to recruit future specialists Source: Eur Respir J, 53 (1) 1802209; 10.1183/13993003.02209-2018 Year: 2019 Transition from paediatric to adult cystic fibrosis care: a developmental framework Source: Eur Respir Monogr 2014; 64: 272-285 Year: 2014 Effective strategies for managing new Pseudomonas cultures in adults with cystic fibrosis Source: Eur Respir J 2015; 46: 862-865 Year: 2015 Idiopathic pulmonary fibrosis: current challenges and future perspectives Source: Eur Respir Rev 2013; 22: 103-105 Year: 2013 Characteristics of cystic fibrosis patients diagnosed after false negative cystic fibrosis newborn screening results Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019 The future for a child born with cystic fibrosis today Source: Breathe 2007; 4: 16-23 Year: 2007 Newborn screening for cystic fibrosis in Spain Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Physical activity for cystic fibrosis: perceptions of people with cystic fibrosis, parents and healthcare professionals Source: ERJ Open Res, 6 (3) 00294-2019; 10.1183/23120541.00294-2019 Year: 2020 Cystic fibrosis: prospects for therapy of some class 1 mutations Source: Annual Congress 2007 - Cystic fibrosis: will the new biology deliver? Year: 2007